Shergill, Ardaman
Mayo Clinic
University of Chicago, Chicago, IL.
Citations 1
Alliance A022106: A Phase II/III Trial of Nab-Paclitaxel and Gemcitabine ± Cisplatin as Second-Line Treatment for BRCA1/2 or PALB2 Mutant Metastatic Pancreatic Du
Shi, Qian , Collisson, Eric A. , Dixon, Jesse G. , Cusnir, Mike , Winograd, Rafael , Botta, Gregory P. , Shergill, Ardaman , Ko, Andrew , Tsang, Erica S , Shi, Qian , Olive, Kenneth P , Collisson, Eric , Dixon, Jesse G , Cusnir, Mike , Winograd, Rafael , Botta, Gregory P , Shergill, Ardaman , Meyerhardt, Jeffrey A , O'Reilly, Eileen M , Ko, Andrew H , Wadlow, Raymond Couric , Meyerhardt, Jeffrey A. , O’Reilly, Eileen M.
JCO Oncology Advances | October 31, 2025 | Volume: No volume available | Issue: 2 | Pages: No page available
